Novartis AG to Discuss Zolgensma (AVXS-101) Clinical Data Call Transcript
Good morning and good afternoon, and welcome to the Zolgensma AAN data investor call and live audio webcast. (Operator Instructions) And the conference is being recorded. (Operator Instructions) A recording of the conference call, including the Q&A session, will be available on our website shortly after the call ends. (Operator Instructions)
With that, I would like to hand over to Mr. Samir Shah, Global Head of Investor Relations. Please go ahead, sir.
Thank you very much, and good morning, everybody, and good afternoon as well. Thank you for taking the time to join us today as we review the clinical data which was presented over the last few days on Zolgensma at the American Academy of Neurology meeting. With us today on the call, we have Paul Hudson, who you all know is the CEO of Novartis Pharmaceuticals; Dave Lennon, who is the President of AveXis, which is a part of the pharmaceuticals group in Novartis; and Olga Santiago, who is the Chief Medical Officer for AveXis.
Before we start, I'm
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
